| scholarly article | Q13442814 |
| P2093 | author name string | Stephan W Morris | |
| Thomas R Webb | |||
| P Jake Slavish | |||
| Qin Jiang | |||
| Xiaoli Cui | |||
| P2860 | cites work | Synthesis of methylene- and difluoromethylenephosphonate analogues of uridine-4-phosphate and 3-deazauridine-4-phosphate | Q79395805 |
| Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile | Q80070517 | ||
| Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors | Q80311130 | ||
| 4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase | Q27648289 | ||
| Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma | Q27851421 | ||
| Activating mutations in ALK provide a therapeutic target in neuroblastoma | Q27851452 | ||
| Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase | Q33232683 | ||
| Generation of new synthetic scaffolds using framework libraries selected and refined via medicinal chemist synthetic expertise | Q33323436 | ||
| Preparation of indoles from alpha-aminonitriles: A short synthesis of FGIN-1-27. | Q34567353 | ||
| An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms | Q34625881 | ||
| Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling | Q36288956 | ||
| Asymmetric carbon-carbon coupling of phenols or anilines with aryllead triacetates. | Q43983734 | ||
| 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta | Q44708058 | ||
| 3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptor | Q44950091 | ||
| Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core | Q46152844 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3308-3316 | |
| P577 | publication date | 2009-03-27 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Design and synthesis of a novel tyrosine kinase inhibitor template | |
| P478 | volume | 17 |
Search more.